Wow! Four days in a trading halt/voluntary suspension and that is all the clarification they are going to give the market? That is absolutely pathetic, but then what more should anyone expect from this company?
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%